510(k) Report

510(k) · Cleared

Cleared

Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200 Rheumatoid Factor

K191562510(k) TraditionalCleared Mar 6, 2020267-day reviewClass II21 CFR 866.5340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Horiba Abx Sas · DBF Ferritin, Antigen, Antiserum, Control

Cleared on Mar 6, 2020 as substantially equivalent to K092505 (Beckman Coulter, Inc., 2009) and 2 other predicates after a 267-day review. Its family tree reaches back 2 generations to 1995.

Decided
Mar 6, 2020
Review
267 days
Class
Class II
Product code
DBF
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K951595 (1995). 4 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2009: 1 other ancestor2006: 1 other ancestorK951595 · Roche Cobas Integra Analyzer, Reagent Cassettes · Roche Diagnostic Systems, Inc. · 1995 · recalledK012393 · Tina-Quant Transferrin Ver.2 · Roche Diagnostics Corp. · 2001199520002005201020152020
  1. Root · 2 generations backK951595 Roche Cobas Integra Analyzer, Reagent CassettesRoche Diagnostic Systems, Inc. · 1995 · Recalled
  2. 1 generation backK012393 Tina-Quant Transferrin Ver.2Roche Diagnostics Corp. · 2001
  3. This deviceK191562 Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200…Horiba Abx Sas · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K951595Roche Cobas Integra Analyzer, Reagent CassettesRoche Diagnostic Systems, Inc.19957
−1K012393Tina-Quant Transferrin Ver.2Roche Diagnostics Corp.2001—
0 (this device)K191562Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200 Rheumatoid…Horiba Abx Sas2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200610
200910
FIG. 1 — Lineage of K191562, 1995–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DBF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DBF device

  1. #1 K193650 LIAISON Ferritinscore 2.0 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092505Beckman Coulter Ferritin Reagent, Model: OSR61203
Summary page 6
…number Yumizen C1200 Ferritin ( OSR61203) BECKMAN COULTER K092505 Ferritin Yumizen C1200 K012393…
Beckman Coulter, Inc.2009—
*K012393Tina-Quant Transferrin Ver.2
Summary page 6
…ritin ( OSR61203) BECKMAN COULTER K092505 Ferritin Yumizen C1200 K012393 Transferrin Model :TRSF2 Roche Diagnostics Transferrin Yumizen C1200 Olympus RF La…
Roche Diagnostics Corp.2001—
*K060201Olympus RF Latex Calibrator, and Olympus RF Latex Reagent with Model (S): ODC0028, and…
Summary page 6
…Transferrin Model :TRSF2 Roche Diagnostics Transferrin Yumizen C1200 Olympus RF Latex reagent K060201 Olympus America, Inc. Rheumatoid Factor (OSR61105) === Page…
Olympus America, Inc.2006—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 18.5 years on median.
  • 1 of the 4 ancestors has a recall of any class.

How does its category compare?

All DBF devices

DBF Ferritin, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · DBF

1in 2021

2009: 12010: 12011: 12012: 12014: 12017: 12020: 12021: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DBF

Too few DBF 510(k)s in any year since 2007 to give a median.

Recalls per year · DBF

3in 2012

2012: 3
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DBF

1in 2025

2012: 12013: 12016: 12017: 22018: 72019: 12020: 12021: 32023: 32024: 12025: 1
2007high 7 (2018) · low 0 (2007)2025

MAUDE reports naming product code DBF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20101—00
20111—00
20121—31
20130—01
20141—00
20150—00
20160—01
20171—02
20180—07
20190—01
20201—01
20211—03
20220—00
20230—03
20240—01
20250—01
20260—0—

What is it indicated for?

Yumizen C1200 Ferritin reagent is intended for the quantitative in vitro diagnostic determination of Ferritin in human serum by latex-enhanced immunoturbidimetric assay. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, hemochromatosis (iron overload) and iron deficiency anemia. Yumizen C1200 Transferrin reagent is intended for the quantitative in vitro diagnostic determination of transferrin in human serum and lithium…

Read the full statement (118 words)

Yumizen C1200 Ferritin reagent is intended for the quantitative in vitro diagnostic determination of Ferritin in human serum by latex-enhanced immunoturbidimetric assay. Measurements of ferritin aid in the diagnosis of diseases affecting iron metabolism, hemochromatosis (iron overload) and iron deficiency anemia.

Yumizen C1200 Transferrin reagent is intended for the quantitative in vitro diagnostic determination of transferrin in human serum and lithium heparin plasma by turbidimetry.

Measurement of transferrin levels aids in the diagnosis of malnutrition, acute inflammation, infection, and iron deficiency anemia.

Yumizen C1200 Rheumatoid Factor reagent is intended for the quantitative in vitro diagnostic determination of rheumatoid factor in human serum by latex-enhanced immunoturbidimetric assay.

Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K191562: Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200 Rheumatoid Factor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191562

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026